If you’re looking for other ways to get your THC or other cannabinoids, your options are a little bit limited right now. Don’t get us wrong. When it comes to delivery methods, there is a huge variety of choices. In addition to the standard practice of smoking cannabis flower, people choose to get their cannabinoids from vaping, edibles, oils, and topical products. There are plenty of choices when it comes to how you want to incorporate cannabinoids into your life, and depending on your needs, you’ll have the opportunity to choose the right one for you. But when it comes to the actual source of the cannabinoids, the window of opportunity is startlingly narrow. The cannabis plant is your only option.
Or is it?
In fact, cannabis is not the only source of cannabinoids out there. We have already reported on cannabinoids such as CBD turning up in such places as the peels of oranges, raising interesting questions about the way cannabinoids are sourced and the way laws are structured in the places where cannabis—and by extension, CBD—is not yet legal.
As for THC itself, though, it has only been found in the cannabis plant. Unfortunately, that’s less than ideal for a number of reasons. THC, which is the primary psychoactive substance in the cannabis plant, isn’t found throughout the entire plant. The stalks, stems, and leaves contain almost zero THC. THC is primarily located on small outgrowths of the plant known as trichomes. If you study your cannabis flower closely, you’ll be able to see these trichomes. In addition, trichomes are responsible for the sticky feeling cannabis flower sometimes has, which is why we refer to stickier flower as being more potent and, in many cases, more desirable.
Because only the trichomes produce cannabinoids, much of the plant is often wasted—although there are some low-yield uses for the stems and leaves. The goal of finding a new cannabinoid source, then, is to reduce waste and to boost yield. This can be done through a little plant bioengineering.
In the past several years, a multitude of companies have begun to experiment with the cannabis genome in order to see what might be possible. The short of it is that cannabinoids no longer have to come from plants at all. When we think of THC, we think of the iconic seven-bladed leaf that has stood for cannabis consumption for decades. But if bioengineering has its way, that token may cease to be relevant. Independent corporations and medical researchers are exploring ways to grow cannabinoids using bacteria. These biosynthetic cannabinoids, made by microbes, can be produced completely in a lab environment, taking plants and growing out of the process entirely.
Is that a good thing? It’s hard to say. In the long term, producing our cannabinoids this way would save money. Right now, cannabis products are fairly expensive, but if they were cultivated in labs, the cost could be reduced to about a fifth of what we currently pay. That’s great for consumers, but maybe not so awesome for the economy. One of the factors that have motivated states to legalize cannabis en masse is the fact that creating a new industry will stimulate the economy and lead to new jobs and a new source of revenue. If cannabis products are rendered less expensive and growers are made obsolete, it might have an adverse effect on the economic stimulus we hoped to see. And if that happens, it’s possible that the push for legalization might slow down in some places.
It’s impossible to know for sure. But one thing is certain—progress is being made.
Looking to find your medical cannabis in a state that hasn’t yet legalized it? It may be tempting to drive across neighboring state lines with more cannabis-friendly laws. However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. Which States Accept Out-of-State MMJ Cards? States That…
The war on drugs facilitated by the federal government has been an utter failure. Despite cannabis remaining a Schedule I classification according to the federal Controlled Substances Act (CSA), meaning that it has no medicinal value, over 30 states in the United States have legalized it for its medicinal use. While this classification will remain…
Gone are the days when cannabis was just an occasional treat—today, it’s a powerful source of holistic healing. According to a 2021 review published in Current Neuropharmacology, targeting the endocannabinoid system with CBD may offer those affected by borderline personality disorder newfound relief and understanding about managing their condition. What Is Borderline Personality Disorder? Borderline…
Three different types of cannabidiol (CBD) oils produced by Charlotte’s Web have been banned by British regulators. The British Food Standards Agency (FSA) has also disqualified approximately 100 CBD products for undisclosed reasons. In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Despite the law’s passing, CBD…
Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. But there may be some good news for those coping with this mental health issue. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar…
We sat down with the team at TerraLeaf, a medical cannabis dispensary servicing West Virginia, to ask them the Veriheal 5—five questions…
A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD)—the primary non-intoxicating constituent of cannabis…
There’s quite a bit of research supporting cannabis’ effectiveness in reducing anxiety. But did you know that certain strains can actually make…